Genome-based identification of cancer genes by proviral tagging in mouse retrovirus-induced T-cell lymphomas

Rachel Kim, Alla Trubetskoy, Takeshi Suzuki, Nancy A. Jenkins, Neal G. Copeland, Jack Lenz

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

The identification of tumor-inducing genes is a driving force for elucidating the molecular mechanisms underlying cancer. Many retroviruses induce tumors by insertion of viral DNA adjacent to cellular oncogenes, resulting in altered expression and/or structure of the encoded proteins. The availability of the mouse genome sequence now allows analysis of retroviral common integration sites in murine tumors to be used as a genetic screen for identification of large numbers of candidate cancer genes. By positioning the sequences of inverse PCR-amplified, virus-host junction fragments within the mouse genome, 19 target genes were identified in T-cell lymphomas induced by the retrovirus SL3-3. The candidate cancer genes included transcription factors (Fos, Gfi1, Lef1, Myb, Myc, Runx3, and Sox3), all three D cyclins, Ras signaling pathway components (Rras2/TC21 and Rasgrp1), and Cmkbr7/CCR7. The most frequent target was Rras2. Insertions as far as 57 kb away from the transcribed portion were associated with substantially increased transcription of Rras2, and no coding sequence mutations, including those typically involved in Ras activation, were detected. These studies demonstrate the power of genome-based analysis of retroviral insertion sites for cancer gene discovery, identify several new genes worth examining for a role in human cancer, and implicate the pathways in which those genes act in lymphomagenesis. They also provide strong genetic evidence that overexpression of unmutated Rras2 contributes to tumorigenesis, thus suggesting that it may also do so if it is inappropriately expressed in human tumors.

Original languageEnglish (US)
Pages (from-to)2056-2062
Number of pages7
JournalJournal of Virology
Volume77
Issue number3
DOIs
StatePublished - Feb 2003

Fingerprint

Retroviridae
T-Cell Lymphoma
Neoplasm Genes
lymphoma
T-lymphocytes
Genome
neoplasms
genome
mice
Neoplasms
genes
Genes
Cyclin D
Viral DNA
Genetic Association Studies
Oncogenes
Carcinogenesis
Transcription Factors
oncogenes
cyclins

ASJC Scopus subject areas

  • Immunology

Cite this

Genome-based identification of cancer genes by proviral tagging in mouse retrovirus-induced T-cell lymphomas. / Kim, Rachel; Trubetskoy, Alla; Suzuki, Takeshi; Jenkins, Nancy A.; Copeland, Neal G.; Lenz, Jack.

In: Journal of Virology, Vol. 77, No. 3, 02.2003, p. 2056-2062.

Research output: Contribution to journalArticle

Kim, Rachel ; Trubetskoy, Alla ; Suzuki, Takeshi ; Jenkins, Nancy A. ; Copeland, Neal G. ; Lenz, Jack. / Genome-based identification of cancer genes by proviral tagging in mouse retrovirus-induced T-cell lymphomas. In: Journal of Virology. 2003 ; Vol. 77, No. 3. pp. 2056-2062.
@article{9da4f820a2824947bf10d82bd07957af,
title = "Genome-based identification of cancer genes by proviral tagging in mouse retrovirus-induced T-cell lymphomas",
abstract = "The identification of tumor-inducing genes is a driving force for elucidating the molecular mechanisms underlying cancer. Many retroviruses induce tumors by insertion of viral DNA adjacent to cellular oncogenes, resulting in altered expression and/or structure of the encoded proteins. The availability of the mouse genome sequence now allows analysis of retroviral common integration sites in murine tumors to be used as a genetic screen for identification of large numbers of candidate cancer genes. By positioning the sequences of inverse PCR-amplified, virus-host junction fragments within the mouse genome, 19 target genes were identified in T-cell lymphomas induced by the retrovirus SL3-3. The candidate cancer genes included transcription factors (Fos, Gfi1, Lef1, Myb, Myc, Runx3, and Sox3), all three D cyclins, Ras signaling pathway components (Rras2/TC21 and Rasgrp1), and Cmkbr7/CCR7. The most frequent target was Rras2. Insertions as far as 57 kb away from the transcribed portion were associated with substantially increased transcription of Rras2, and no coding sequence mutations, including those typically involved in Ras activation, were detected. These studies demonstrate the power of genome-based analysis of retroviral insertion sites for cancer gene discovery, identify several new genes worth examining for a role in human cancer, and implicate the pathways in which those genes act in lymphomagenesis. They also provide strong genetic evidence that overexpression of unmutated Rras2 contributes to tumorigenesis, thus suggesting that it may also do so if it is inappropriately expressed in human tumors.",
author = "Rachel Kim and Alla Trubetskoy and Takeshi Suzuki and Jenkins, {Nancy A.} and Copeland, {Neal G.} and Jack Lenz",
year = "2003",
month = "2",
doi = "10.1128/JVI.77.3.2056-2062.2003",
language = "English (US)",
volume = "77",
pages = "2056--2062",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "3",

}

TY - JOUR

T1 - Genome-based identification of cancer genes by proviral tagging in mouse retrovirus-induced T-cell lymphomas

AU - Kim, Rachel

AU - Trubetskoy, Alla

AU - Suzuki, Takeshi

AU - Jenkins, Nancy A.

AU - Copeland, Neal G.

AU - Lenz, Jack

PY - 2003/2

Y1 - 2003/2

N2 - The identification of tumor-inducing genes is a driving force for elucidating the molecular mechanisms underlying cancer. Many retroviruses induce tumors by insertion of viral DNA adjacent to cellular oncogenes, resulting in altered expression and/or structure of the encoded proteins. The availability of the mouse genome sequence now allows analysis of retroviral common integration sites in murine tumors to be used as a genetic screen for identification of large numbers of candidate cancer genes. By positioning the sequences of inverse PCR-amplified, virus-host junction fragments within the mouse genome, 19 target genes were identified in T-cell lymphomas induced by the retrovirus SL3-3. The candidate cancer genes included transcription factors (Fos, Gfi1, Lef1, Myb, Myc, Runx3, and Sox3), all three D cyclins, Ras signaling pathway components (Rras2/TC21 and Rasgrp1), and Cmkbr7/CCR7. The most frequent target was Rras2. Insertions as far as 57 kb away from the transcribed portion were associated with substantially increased transcription of Rras2, and no coding sequence mutations, including those typically involved in Ras activation, were detected. These studies demonstrate the power of genome-based analysis of retroviral insertion sites for cancer gene discovery, identify several new genes worth examining for a role in human cancer, and implicate the pathways in which those genes act in lymphomagenesis. They also provide strong genetic evidence that overexpression of unmutated Rras2 contributes to tumorigenesis, thus suggesting that it may also do so if it is inappropriately expressed in human tumors.

AB - The identification of tumor-inducing genes is a driving force for elucidating the molecular mechanisms underlying cancer. Many retroviruses induce tumors by insertion of viral DNA adjacent to cellular oncogenes, resulting in altered expression and/or structure of the encoded proteins. The availability of the mouse genome sequence now allows analysis of retroviral common integration sites in murine tumors to be used as a genetic screen for identification of large numbers of candidate cancer genes. By positioning the sequences of inverse PCR-amplified, virus-host junction fragments within the mouse genome, 19 target genes were identified in T-cell lymphomas induced by the retrovirus SL3-3. The candidate cancer genes included transcription factors (Fos, Gfi1, Lef1, Myb, Myc, Runx3, and Sox3), all three D cyclins, Ras signaling pathway components (Rras2/TC21 and Rasgrp1), and Cmkbr7/CCR7. The most frequent target was Rras2. Insertions as far as 57 kb away from the transcribed portion were associated with substantially increased transcription of Rras2, and no coding sequence mutations, including those typically involved in Ras activation, were detected. These studies demonstrate the power of genome-based analysis of retroviral insertion sites for cancer gene discovery, identify several new genes worth examining for a role in human cancer, and implicate the pathways in which those genes act in lymphomagenesis. They also provide strong genetic evidence that overexpression of unmutated Rras2 contributes to tumorigenesis, thus suggesting that it may also do so if it is inappropriately expressed in human tumors.

UR - http://www.scopus.com/inward/record.url?scp=0037301370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037301370&partnerID=8YFLogxK

U2 - 10.1128/JVI.77.3.2056-2062.2003

DO - 10.1128/JVI.77.3.2056-2062.2003

M3 - Article

VL - 77

SP - 2056

EP - 2062

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 3

ER -